Risk factors for treatment failure in scabies: a cohort study.

Area of Science:

• Dermatology
• Infectious Diseases
• Public Health

Background:

• Scabies treatment failure affects approximately one-third of patients, contributing to its rising incidence in developed nations.
• Understanding treatment failure is crucial for effective scabies management and control.

Purpose of the Study:

• To identify key predictors of treatment failure in ambulatory scabies populations.
• To inform clinical practice and improve patient outcomes for scabies.

Main Methods:

• A multicenter study compared successful scabies treatment outcomes with treatment failures.
• 210 patients were analyzed, with 98 in the success group and 112 in the failure group.
• Risk factors were assessed through clinical characteristics and treatment modalities, including medication type, dosage, and environmental decontamination.

Main Results:

• Significant predictors of treatment failure included using a single treatment (topical benzyl benzoate or oral ivermectin) versus combination therapy.
• Single oral ivermectin intake and administration on an empty stomach increased failure risk.
• Absence of decontamination for furnishings (sofas, mattresses, car seats) and lack of clear treatment instructions were strongly associated with treatment failure.

Conclusions:

• Topical benzyl benzoate monotherapy and single-dose oral ivermectin are significant predictors of scabies treatment failure.
• Comprehensive treatment protocols involving combination therapy, appropriate ivermectin dosing, and thorough environmental decontamination are essential for successful scabies eradication.